Craig Hunsaker Sells 33,602 Shares of Alphatec (NASDAQ:ATEC) Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC) EVP Craig Hunsaker sold 33,602 shares of the business’s stock in a transaction on Friday, March 6th. The stock was sold at an average price of $12.22, for a total transaction of $410,616.44. Following the transaction, the executive vice president owned 1,808,974 shares of the company’s stock, valued at approximately $22,105,662.28. The trade was a 1.82% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Alphatec Stock Performance

NASDAQ:ATEC opened at $12.66 on Thursday. Alphatec Holdings, Inc. has a 12 month low of $8.81 and a 12 month high of $23.29. The company has a debt-to-equity ratio of 40.35, a current ratio of 2.06 and a quick ratio of 1.28. The firm has a market capitalization of $1.92 billion, a PE ratio of -13.33 and a beta of 1.02. The business’s fifty day moving average price is $15.45 and its 200 day moving average price is $16.93.

Alphatec (NASDAQ:ATEC) last announced its quarterly earnings results on Tuesday, February 24th. The medical technology company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The business had revenue of $212.93 million for the quarter, compared to analysts’ expectations of $212.67 million. The firm’s quarterly revenue was up 20.4% on a year-over-year basis. During the same period last year, the firm earned ($0.23) earnings per share. On average, sell-side analysts anticipate that Alphatec Holdings, Inc. will post -1.08 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Aster Capital Management DIFC Ltd acquired a new stake in shares of Alphatec in the third quarter valued at approximately $34,000. Osterweis Capital Management Inc. purchased a new stake in Alphatec in the 2nd quarter valued at $37,000. Northwestern Mutual Wealth Management Co. raised its position in Alphatec by 157.1% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,571 shares of the medical technology company’s stock valued at $54,000 after purchasing an additional 1,571 shares during the last quarter. China Universal Asset Management Co. Ltd. acquired a new stake in Alphatec during the 3rd quarter worth $73,000. Finally, FNY Investment Advisers LLC acquired a new stake in Alphatec during the 3rd quarter worth $74,000. Institutional investors and hedge funds own 66.35% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on ATEC shares. Barclays upped their price target on Alphatec from $23.00 to $27.00 and gave the company an “overweight” rating in a report on Wednesday, January 7th. Wall Street Zen raised shares of Alphatec from a “hold” rating to a “buy” rating in a report on Saturday, January 31st. TD Cowen restated a “buy” rating on shares of Alphatec in a report on Tuesday, January 27th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Alphatec in a research report on Monday, December 29th. Finally, Lake Street Capital reiterated a “buy” rating on shares of Alphatec in a research note on Wednesday, February 25th. Ten investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $22.82.

About Alphatec

Alphatec Holdings, Inc (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.

Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.